Bradmer Pharmaceuticals Inc. (TSE:GLX) Receives Average Recommendation of “Buy” from Brokerages

Bradmer Pharmaceuticals Inc. (TSE:GLX) has been assigned an average rating of “Buy” from the eight brokerages that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and five have given a strong buy rating to the company.

Several research firms have issued reports on GLX. Citigroup upgraded Bradmer Pharmaceuticals to a “hold” rating in a research report on Tuesday, February 24th. ATB Cormark Capital Markets cut Bradmer Pharmaceuticals from a “strong-buy” rating to a “moderate buy” rating in a report on Thursday, February 5th. Finally, Citizens Jmp upgraded Bradmer Pharmaceuticals to a “strong-buy” rating in a report on Tuesday, December 9th.

Bradmer Pharmaceuticals Stock Performance